IMPACT was the first randomised controlled trial (RCT) to assess the efficacy and safety of the FreeStyle Libre system vs. self-monitoring of blood glucose (SMBG) for glucose monitoring in adults with well-controlled type 1 diabetes.1
Published in The Lancet, the IMPACT study was a multicentre, prospective, non-masked RCT by Bolinder et al.
Stay connected